Cavernous hemangioma: a rare cause for secondary parkinsonism: a case report.
A 72-year-old female was admitted to our outpatient clinic with the complaints of slowed movements and sudden speeding up of her walk. She was identified to have cavernous angioma with left basal ganglion localization. The patient did not demonstrate a levodopa response and refused to have surgical treatment. The cause underlying this clinical presentation was identified as the chronic pressure brought forward by the cavernous hemangioma. We present this patient as a case report, because cavernous angioma with basal ganglia localization is an unusual cause of secondary parkinsonism.
Alp
Recep
R
Faculty of Medicine, Department of Neurology, Kafkas University, Kars, Turkey. recepalp@hotmail.com
Alp
Selen Ilhan
SI
Ure
Hikmet
H
D000368:Aged; D000978:Antiparkinson Agents / Q000008:administration & dosage; D001480:Basal Ganglia Diseases / Q000473:pathology* / Q000503:physiopathology; D002230:Carbidopa / Q000008:administration & dosage; D005260:Female; D005917:Globus Pallidus / Q000473:pathology / Q000503:physiopathology; D020786:Hemangioma, Cavernous, Central Nervous System / Q000150:complications* / Q000473:pathology* / Q000503:physiopathology; D006801:Humans; D007980:Levodopa / Q000008:administration & dosage; D008279:Magnetic Resonance Imaging; D020734:Parkinsonian Disorders / Q000209:etiology* / Q000473:pathology* / Q000503:physiopathology; D011699:Putamen / Q000473:pathology / Q000503:physiopathology; D014057:Tomography, X-Ray Computed; D017211:Treatment Failure
D000978:Antiparkinson Agents; D007980:Levodopa; D002230:Carbidopa